EN DE
STOCK COMPARISON

Gilead Sciences vs UnitedHealth Group: Fair Value & Quality

Both stocks run through our valuation models. Here is how Gilead Sciences (GILD) and UnitedHealth Group (UNH) compare, as of Sep 12, 2026.

As of Sep 12, 2026, Fair Value Calculator sees UnitedHealth Group as the more attractively valued of the two: Gilead Sciences trades at $144 versus a fair value of $147 (+2%), while UnitedHealth Group trades at $379 versus $526 (+39%).
Gilead Sciences
GILD · USD · Health Care
+2%
upside to fair value
fairly valued
Price$144
Fair Value$147
Quality83/100
UnitedHealth Group
UNH · USD · Health Care
+39%
upside to fair value
undervalued
Price$379
Fair Value$526
Quality62/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Gilead SciencesUnitedHealth Group
Valuation
18.5×P/E (TTM)31.9×
5.61×P/S (TTM)0.86×
7.37×P/B4.09×
12.3×EV/EBITDA20.2×
2.14×PEG1.49×
+1.9%Fair value upside+38.7%
2.1%Dividend yield2.2%
$3.19Dividend per share$8.84
Profitability
39%Operating margin8%
2.41×EBIT margin trend (5Y)0.48×
43%Return on equity12%
13%Return on assets4%
Growth
4%Revenue growth (YoY)2%
2.6%Avg. growth/yr (3Y)11.4%
3.6%Avg. growth/yr (5Y)11.7%
+10.5%Value creation/yr−0.4%
Balance & size
11.4×Interest coverage (EBIT/interest)4.7×
0.98×Debt / equity0.77×
$167BMarket cap$384B
healthyGrowth qualitymixed

Even match: 8 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Gilead Sciencesof which business quality 78 · market factors 68 UnitedHealth Groupof which business quality 60 · market factors 63
ProfitabilityMargins and returns on capital today
77
52
Quality GrowthAre margins and returns improving?
67
48
CashflowEarnings quality: real cash, not paper profit
86
52
Fin. StrengthBalance sheet, leverage, solvency risk
64
51
InvestmentDisciplined investing over empire-building
97
76
Low VolatilityCalm price path (market factor)
87
72
MomentumPrice trend over the last 3–12 months (market factor)
55
60
52W MomentumDistance to the 52-week high (market factor)
71
56
Net IssuanceBuybacks instead of dilution
83
99

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyGilead SciencesPrice $144UnitedHealth GroupPrice $379
DCF Models+55%above the price$222-4%close to the price$362
Earnings-Based+1%close to the price$145-48%below the price$196
Dividend Discount-61%below the price$56.73n/a
Multiples-19%below the price$116-32%below the price$259
Asset-Based-92%below the price$12.21-82%below the price$69.43
Growth DCF+16%above the price$167+1%close to the price$382
Economic Profit-32%below the price$98.10-51%below the price$186
Growth Earnings+38%above the price$199-23%below the price$292
Minimum-92%below the price$12.21-82%below the price$69.43
Maximum+55%above the price$222+1%close to the price$382
Median-9%close to the price$130-32%below the price$259
Geometric mean-32%below the price$97.83-41%below the price$222

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Gilead Sciences: 11 of 26 models see the stock below the current price.

UnitedHealth Group: 19 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Gilead Sciences
Bear $106Fair Value $147Bull $258
$144 = current price (white tick)
UnitedHealth Group
Bear $368Fair Value $526Bull $657
$379 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Gilead Sciences · Health Care

Quality score83 · Top 25%
Fair value upside+2% · above median

UnitedHealth Group · Health Care

Quality score62 · above median
Fair value upside+39% · Top 25%

Bottom line

As of Sep 12, 2026, Fair Value Calculator sees UnitedHealth Group as the more attractively valued of the two: Gilead Sciences trades at $144 versus a fair value of $147 (+2%), while UnitedHealth Group trades at $379 versus $526 (+39%).

Gilead Sciences has the higher quality score (83/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.